Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sitagliptin or BeiDouGen Capsule Improve the Pregnancy Outcome in Patients with PCOS

NCT06587698 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT06587698
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06587698 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sitagliptin or BeiDouGen Capsule Improve the Pregnancy Outcome in Patients with PCOS
Lead sponsor
Peking University Third Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
August 21, 2024
Completion date
July 1, 2029
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

polycystic ovarian syndrome